Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65,000,000
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
19,170,288
-
Shares change
-
+441,521
-
Total reported value, excl. options
-
$569,347,585
-
Value change
-
+$16,106,841
-
Put/Call ratio
-
94.2%
-
Number of buys
-
47
-
Number of sells
-
-39
-
Price
-
$29.7
Significant Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q3 2016
102 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share as of Q3 2016.
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) has 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19,170,288 shares
of 65,000,000 outstanding shares and own 29.49% of the company stock.
Largest 10 shareholders include FMR LLC (3,929,462 shares), BVF INC/IL (2,765,080 shares), WELLINGTON MANAGEMENT GROUP LLP (1,122,216 shares), BlackRock Fund Advisors (911,788 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (910,621 shares), VICTORY CAPITAL MANAGEMENT INC (815,410 shares), Opaleye Management Inc. (785,000 shares), VANGUARD GROUP INC (712,475 shares), Boxer Capital, LLC (705,159 shares), and FIL Ltd (629,064 shares).
This table shows the top 87 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.